PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Yahoo Finance [Yahoo! Finance]
Purple Biotech Regains Compliance with Nasdaq
Purple Biotech (PPBT) was downgraded by Zacks Research from "hold" to "strong sell".
Purple Biotech (PPBT) had its price target lowered by HC Wainwright from $34.00 to $30.00. They now have a "buy" rating on the stock.
Form 3 PURPLE BIOTECH LTD. For: Mar 18 Filed by: Lankry Shai S
Form 6-K PURPLE BIOTECH LTD. For: Mar 25
Form 6-K PURPLE BIOTECH LTD. For: Mar 18
Form 20-F PURPLE BIOTECH LTD. For: Dec 31
Form 3 PURPLE BIOTECH LTD. For: Mar 18 Filed by: Gagnon Robert E.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.